Each company spent more than 15% of their revenue on research.
Article source: Danielle Kirsh, Medical Design and Outsourcing
These 10 medtech companies have spent the largest share of their annual sales on R&D, according to Medical Design & Outsourcing‘s annual Big 100. Here’s a look at the research-related news each medical device developer accomplished in 2022.
As an indicator of how well the industry is performing, we also compile and calculate R&D spending figures. Our latest analysis found medtech sales set a new record high and R&D spending accelerated despite economic headwinds.
Annual R&D spending at large medical device companies grew more than $1.1 billion — or 5.1% — to $23.4 billion, according to the most recent data available in our Big 100 analysis.